Ray Sachs, UCB. Computational Radiation Biology
Home
Research
Grants:
NSF
NIH
arrow pointing downward to
the information on this page DOE arrow pointing downward to
the information on this page
 

Skip to bystander effect DOE grant halfway down this page.

Modeling the interrelations among radiation-induced bystander effects, genomic instability, and cancer risk.
DOE grant. Sachs PI. 2003-2005
Abstract and specific aims
Bystander effects are considered important to radiation risk, especially for low doses of high LET radiation, where few cells are hit directly. The objective of the proposed research is to develop quantitative estimates of radiation bystander effects applicable to low dose radiation risk estimation. Mathematical formalisms and software will be designed for determining a key bystander effect parameter, the influence number. In addition, qualitative scenarios in the literature for interrelations between the bystander effect and genomic instability will be adapted to risk estimation by making them quantitative. These two specifically focused projects will be integrated into the broader, multi-group, cooperative modeling effort on radiation risk using an archetype called for in the Program Announcement.
The three specific aims are the following.
Aim 1. Computational modeling of bystander signal influence number for tissues and for multicellular in vitro systems. A key parameter for analyses of bystander effects, especially for risk estimation, is the average number, N, of cells close enough to a cell sending out bystander signal that they can be strongly influenced by the signal. This "influence number" N is related to signal range in each particular situation. Typically, the larger N is, the smaller is the high LET dose sufficient to elicit most of the bystander response in the multicellular system. Our pioneering quantitative model of radiation bystander effects has recently been generalized by several groups. By estimating influence number N using dose-response relations, the model was applied to radon risk estimation. At present, estimates of N from epidemiological data on human lung cancer vary widely. In recent experiments at Columbia using human 3-D artificial human tissue systems the range found for bystander signals is ~1 mm, corresponding to large values of N; large values of N, up to ~1000 in some cases, have also been found for some other multicellular in vitro systems. We will develop mathematical bystander effect models for systematic and quantitative estimates of influence number N. Various in vivo and 2-D or 3-D in vitro multicellular systems will be considered. We shall refine previous methods that were used to estimate N from localized irradiation experiments such as microbeam experiments and from dose response relations. In addition, N will be estimated using models for intercellular signaling. Classic reaction-diffusion equations for the signaling molecule(s) may be an adequate approximation in many cases. More complex scenarios involving specifics on gap junctions or extracellular signaling (e.g. by cytokines/growth factors) are also needed. Various groups have recently developed, for a variety of biological situations, a number of deterministic and stochastic computational models for intercellular signaling. Appropriate quantitative approaches of this kind in the literature will be adapted to the available experimental evidence on radiation bystander effects, which is now rapidly accumulating, and used to estimate N. We will start with models having a minimum of adjustable parameters, then gradually generalize.
Aim 2. Modeling bystander/instability interrelations. Qualitative mechanistic models have been suggested by several different groups for bystander effects inducing genomic instability and for bystander signaling arising a number of cell generations after irradiation. These qualitative models will be quantified and made more specific, emphasizing chromosomal instability. In addition to being central to low dose risk estimation, establishing bystander signal influence number N (aim 1) can give estimates of effective target size for radiation, relevant to the large target size sometimes found experimentally for chromosomal instability. Our quantifications of bystander/instability interrelations will incorporate recent results on instability in non-irradiated cells, and on bystander signals from progeny of irradiated cells. Emphasis will be on stochastic models of bystander/instability interrelations. Stochastic models are computationally more intensive than corresponding deterministic ones, but are superior at analyzing cell-to-cell fluctuations, are usually conceptually clearer, are sometimes equally parsimonious as regards the number of adjustable parameters, and are particularly convenient for estimating statistical significance during model validation.
Aim 3. Cooperative radiation risk modeling using an archetype. The two aims above will be quite focused: we plan to start with the simplest applicable quantitative models, use particular data sets to fix parameters for each particular model and test its hypotheses, initially keep the number of adjustable parameters to a minimum, and gradually move from highly specific models to somewhat more general ones. The Low-Dose Radiation Risk Program Announcement also calls for more comprehensive, coordinated risk modeling jointly by the different funded groups, using a biological archetype, i.e. a computational model of a biological system. The archetype choice is to be determined by discussions among the different groups. Results from specific aims 1 and 2 will be incorporated into this multi-group, cooperative risk modeling effort, especially as regards extrapolating results from higher to lower doses. We anticipate that this multi-group, cooperative project will be more integrative, i.e. deal with a broader range of effects, have more adjustable parameters, and involve more modular subunits compared to narrower projects such as those of specific aims 1 and 2.

Back to top of page, for signaling grant and links to other pages on this site.

Significance of the Bystander Effect
Sachs Subcontract. DOE grant. Columbia University, DJ Brenner PI, 2001-2004

Abstract

There has been much recent interest in responses in cells which are not themselves struck by a radiation track, but are "bystanders" of a directly hit cell. Bystander-mediated effects could have profound implications for low-dose risk estimation, where many cells are not directly hit. Work from many laboratories has covered a broad spectrum of endpoints showing bystander effects; however, in parallel to this experimental work, there has been little quantitative modeling of the bystander effect which would facilitate systematic experimental design, or permit consideration of its implications (if any) for radiation risk estimation, at low doses, at low LET, or at low dose rate. Our goal is to develop tractable, testable, biophysical models describing bystander effects to use as a bridge between A) experimental data on bystander effects (from our own and other labs), and B) low-dose risk estimation. These biophysical model

We have developed a preliminary biologically-based model formalism for bystander effects. This formalism considers the overall radiobiological response as a sum of both "direct" damage and bystander-mediated damage. It encompasses several more specific models and further experimentation is needed to test and differentiate between them. At present the formalism applies to acute doses of high-LET radiation, and a key goal is the extension to lower doses per hit cell, to lower LETs, and to more protracted irradiation. Specific goals relate to

  1. DOSE: Use our current models to define additional key low-dose high-LET experiments, which will be undertaken at the Columbia microbeam facility. These high-statistics chromosome aberration and transformation experiments will involve microbeam and broad-beam irradiations with 0, 1 and 2 alpha particles, the results of which are central to refining biophysical bystander models. In addition, we shall compare yields of complex chromosome aberrations (a marker of high-LET type damage) in those situations where more or less bystander-induced damage is expected, with the goal of understanding the nature of the bystander-induced damage. The results of these experiments will be used to refine our models of high-LET bystander responses.
  2. RADIATION TYPE: Both from a mechanistic and a public-health perspective, it is important to extend these bystander studies to sparsely-ionizing radiation. Mechanistically, we can then study the effect of smaller amounts of energy in hit cells, while from a public health perspective, in any given month about 90% of all our cells are actually non-hit bystanders to low-LET damaged cells. We will use 9 keV/m protons in these low-LET microbeam studies. We shall modify the current formalism so that it includes low-LET radiation, and design and perform experiments, similarly motivated to those in Goal 1, to specifically test mechanisms of low-LET bystander effects. The results will in turn be used to improve our initial models of low-LET bystander-mediated response.
  3. DOSE PROTRACTION: Our preliminary models of the bystander effect strongly suggest the possibility of inverse dose-rate effects, where increased protraction at a given dose could increase the bystander effect. With both mechanistic and pragmatic motivations, we will design and perform experiments in which a given proportion of cells are microbeam irradiated with exact numbers of particles, and the procedure repeated several hours later, either on the same or a different group of cells on the dish. The results will be compared to the corresponding acute irradiations, and the conclusions from these studies will be fed back into the biophysical models.
  4. SIGNIFICANCE: The improved biophysical models, which we will refine using experimental results both from our own experiments as well from other laboratories, will be used to make an overall best assessment of the public-health significance of bystander-mediated responses at low doses, both at low and high LET, and at low and high dose rates.

back to top of page